Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1988]
News [3224]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Study of the efficacy and safety of siltuximab, an anti-interleukin-6...
Dr Raymond Wong - Chinese University of Hong Kong
Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease ( Dr Raymond Wong - Chinese University of Hong Kong )
8 Dec 2013
Results from the randomised phase III Children’s Oncology Group (COG) trial...
Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531 ( Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA )
8 Dec 2013
Final stage II results of the CLL11 trial
Dr Valentin Goede - University of Cologne, Germany
Final stage II results of the CLL11 trial ( Dr Valentin Goede - University of Cologne, Germany )
8 Dec 2013
Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause...
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regression of malignancy ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
7 Dec 2013
Equality of access to transplant for ethnic minority patients
Dr Robert Lown - University College London, UK
Equality of access to transplant for ethnic minority patients ( Dr Robert Lown - University College London, UK )
7 Dec 2013
Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
7 Dec 2013
Encouraging outcomes in older patients following nonmyeloablative...
Dr Yvette Kasamon - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation ( Dr Yvette Kasamon - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
7 Dec 2013
Immune reconstitution and preliminary safety analysis of somatic gene therapy
Dr Sung-Yun Pai - Harvard Medical School, Boston, USA
Immune reconstitution and preliminary safety analysis of somatic gene therapy ( Dr Sung-Yun Pai - Harvard Medical School, Boston, USA )
7 Dec 2013
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome...
Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The...
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction ( Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands )
3 Dec 2013
Cancer cells and the immune system: a natural story?
Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France
Cancer cells and the immune system: a natural story? ( Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France )
3 Dec 2013
Why are Immuno-Oncology compounds different?
Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013
Immuno-Oncology: a concept or already a reality?
Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK
Immuno-Oncology: a concept or already a reality? ( Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK )
3 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation